Our Pipeline

We are advancing a pipeline of differentiated sGC stimulator programs with properties tailored for distinct serious and orphan diseases with significant unmet clinical need. We have several pipeline catalysts expected in 2020.


*Status of sGC programs as of January 13, 2020. Represents ongoing phase of development; does not correspond to the initiation or completion of a particular phase.

Download PDF